2[2]Ryu BR, Choi DW, Hartley DW, et al. Attenuation of cortical neuronal apoptosis by gangliosides. J Pharmacol Exp Ther, 1999, 290(2) :811 ～816.
3[3]Lazarewiez JW, Salinska E, Matyja E, et al. Ganglioside GM 1 preventsN - methyl - D - aspartate neurotoxicity in rabbit hippocampus in vivo:Effect on calcium homeostasis. Mol Chem Neuropathol, 1995,24( 2 ～ 3):165～ 177.
4[4]Tan WK, Williams CE,Gunn AJ,et al. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic - ischemic injury.without causing systemic compromise. Pediatr Res, 1993,34(1):18～22.
6[6]Lenzi GL,Grigoletto F,Gent M,et al. Early treatment of stroke with monosialoganglioside GM1 Efficacy and safety results of the Early Stroke Trial. Stroke, 1994,25(8):1552 ～ 1558.
9Marconi S, De Toni L, Lovato L. Expression of gangliosides on gtial and neuronal cells in normal and pathological adult human brain [J].J Neuroimmunol,2005 Dec 30,170(1--2):115--21.
10Chalimoniuk M, Stepien A, Strosznajder JB. Pergolide Mesylase, a Dopaminergic Receptor A gonist, Applied W ith L--DOPA Enhances Serum Antioxidant Enzym e Activity in Parkinson Disease [J]. Clin Neuropharmacol,2004,27:223--229.
